This inventor holds 2 USPTO granted patents. Top assignees: Tanabe Seiyaku Company, Limited, Tnanbe Seiyaku Co., Ltd.. Active years: 1984-1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1984-1991
Title: Kozo Yamamoto: Innovator in Pharmaceutical Chemistry
Introduction
Kozo Yamamoto is a prominent inventor based in Takatsuki, Japan, known for his contributions to pharmaceutical chemistry. With a total of two patents to his name, he has developed innovative compounds that significantly impact the medical field, particularly in the treatment of autoimmune diseases.
Latest Patents
Yamamoto's latest inventions include an imidazoline derivative, which features a unique formula effective as an immunomodulator. This compound is particularly beneficial for the treatment and prophylaxis of rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, and rheumatic fever. Additionally, he has devised a process for preparing L-malic acid, where polymerization occurs with acryl or allyl monomers in an aqueous suspension containing a fumarase-producing microorganism. This innovative method allows for the production of L-malic acid without the by-product succinic acid, enhancing efficiency in pharmaceutical applications.
Career Highlights
Throughout his career, Kozo Yamamoto has worked with notable companies, including Tanabe Seiyaku Company, Limited, and Tanabe Seiyaku Co., Ltd. His experience within these organizations has enabled him to refine his research and development skills, leading to groundbreaking inventions in his field.
Collaborations
Yamamoto has also collaborated with esteemed colleagues such as Kazuo Matsumoto and Mamoru Suzuki. Their collective knowledge and expertise have contributed to the successful development of innovative solutions and advancements in pharmaceutical sciences.
Conclusion
Kozo Yamamoto continues to be an influential figure in the realm of pharmaceutical innovation. With his focus on developing essential compounds for treating significant medical conditions, his work remains vital to advancing healthcare solutions and improving patients' lives globally.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile